肺腺癌分类的进展：国际多学科新分类系统（IASLC/ATS/ERS）概述
Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).
作者信息
Tang Elizabeth R, Schreiner Andrew M, Pua Bradley B
机构信息
1 Department of Radiology, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA ; 2 Department of Pathology, 3 Division of Interventional Radiology, Department of Radiology, Weill Cornell Medical College, NewYork-Presbyterian Hospital, 525 East 68th Street, New York, NY 10065, USA.
出版信息
J Thorac Dis. 2014 Oct;6(Suppl 5):S489-501. doi: 10.3978/j.issn.2072-1439.2014.09.12.
Abstract
Due to advances in the understanding of lung adenocarcinoma since the advent of its 2004 World Health System classification, an international multidisciplinary panel [sponsored by the International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS), and European Respiratory Society (ERS)] has recently updated the classification system for lung adenocarcinoma, the most common histologic type of lung cancer. Here, we summarize and highlight the new criteria and terminology, certain aspects of its clinical relevance and its potential treatment impact, and future avenues of research related to the new system.
摘要
自2004年世界卫生系统对肺腺癌进行分类以来，由于对肺腺癌的认识取得了进展，一个由国际肺癌研究协会（IASLC）、美国胸科学会（ATS）和欧洲呼吸学会（ERS）赞助的国际多学科小组最近更新了肺腺癌的分类系统，肺腺癌是肺癌最常见的组织学类型。在此，我们总结并强调新的标准和术语、其临床相关性的某些方面及其潜在的治疗影响，以及与新系统相关的未来研究方向。
相似文献
1
Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).肺腺癌分类的进展：国际多学科新分类系统（IASLC/ATS/ERS）概述
J Thorac Dis. 2014 Oct;6(Suppl 5):S489-501. doi: 10.3978/j.issn.2072-1439.2014.09.12.
2
The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects.从临床角度看国际肺癌研究协会/美国胸科学会/欧洲呼吸学会新的肺腺癌分类：当前概念与未来展望
J Thorac Dis. 2014 Oct;6(Suppl 5):S526-36. doi: 10.3978/j.issn.2072-1439.2014.01.27.
3
Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.IASLC/ATS/ERS 新分类定义的肿瘤侵袭性对病理分期为 IA 期肺腺癌具有预后意义，并可通过影像学参数预测。
J Thorac Cardiovasc Surg. 2014 Jan;147(1):54-9. doi: 10.1016/j.jtcvs.2013.08.058. Epub 2013 Oct 13.
4
Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.采用国际肺癌研究协会/美国胸科学会/欧洲呼吸学会（IASLC/ATS/ERS）提出的肺腺癌分类方法对肺腺癌进行细胞学亚型分类。
Cancer Cytopathol. 2013 Nov;121(11):629-37. doi: 10.1002/cncy.21314. Epub 2013 Aug 13.
5
Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会新分类在ⅠB期肺腺癌中的预后价值
Eur J Surg Oncol. 2015 Oct;41(10):1430-6. doi: 10.1016/j.ejso.2015.06.004. Epub 2015 Jun 23.
6
Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma.双基因特征提高了IASLC/ATS/ERS分类对早期肺腺癌患者生存预测的鉴别能力。
Onco Targets Ther. 2016 Jul 25;9:4583-91. doi: 10.2147/OTT.S107272. eCollection 2016.
7
Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.肺腺癌：分子生物学、治疗及国际肺癌研究协会/美国胸科学会/欧洲呼吸学会分类的最新进展的影响
J Thorac Dis. 2014 Oct;6(Suppl 5):S502-25. doi: 10.3978/j.issn.2072-1439.2014.05.19.
8
The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.国际肺癌研究协会（IASLC）-美国胸科学会（ATS）-欧洲呼吸学会（ERS）新的肺腺癌分类：外科医生应了解的内容。
Semin Thorac Cardiovasc Surg. 2014 Autumn;26(3):210-22. doi: 10.1053/j.semtcvs.2014.09.002. Epub 2014 Sep 16.
9
The new 2011 international association for the study of lung cancer/american thoracic society/european respiratory society classification of lung adenocarcinoma in resected specimens: clinicopathologic relevance and emerging issues.2011年国际肺癌研究协会/美国胸科学会/欧洲呼吸学会关于切除标本中肺腺癌的新分类：临床病理相关性及新出现的问题
Korean J Pathol. 2013 Aug;47(4):316-25. doi: 10.4132/KoreanJPathol.2013.47.4.316. Epub 2013 Aug 26.
10
The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management.2011年国际肺癌研究协会/美国胸科学会/欧洲呼吸学会肺腺癌分类：肺癌个体化治疗的一个里程碑。
J Thorac Dis. 2014 Oct;6(Suppl 5):S589-96. doi: 10.3978/j.issn.2072-1439.2014.09.15.
引用本文的文献
1
A Comprehensive Evaluation of Clinicopathologic Characteristics, Molecular Features and Prognosis in Lung Adenocarcinoma with an Acinar Component.伴有腺泡成分的肺腺癌的临床病理特征、分子特征及预后的综合评估
Cancers (Basel). 2025 May 30;17(11):1825. doi: 10.3390/cancers17111825.
2
Excessive MYC Orchestrates Macrophages induced Chromatin Remodeling to Sustain Micropapillary-Patterned Malignancy in Lung Adenocarcinoma.过度的MYC调控巨噬细胞诱导的染色质重塑以维持肺腺癌中的微乳头模式恶性肿瘤。
Adv Sci (Weinh). 2025 Mar;12(12):e2403851. doi: 10.1002/advs.202403851. Epub 2025 Feb 3.
3
A rare presentation of primary lung adenocarcinoma mimicking bilateral interstitial infiltration: A case report and literature review.原发性肺腺癌罕见表现为双侧间质性浸润：一例报告及文献复习
Int J Surg Case Rep. 2025 Feb;127:110899. doi: 10.1016/j.ijscr.2025.110899. Epub 2025 Jan 15.
4
Lung adenocarcinoma presenting as miliary lung metastasis on imaging.影像学表现为粟粒性肺转移的肺腺癌
Radiol Case Rep. 2024 Aug 9;19(11):4702-4707. doi: 10.1016/j.radcr.2024.07.024. eCollection 2024 Nov.
5
Alveolar type I cells can give rise to KRAS-induced lung adenocarcinoma.肺泡 I 型细胞能够产生 KRAS 诱导的肺腺癌。
Cell Rep. 2023 Dec 26;42(12):113286. doi: 10.1016/j.celrep.2023.113286. Epub 2023 Nov 22.
6
Comparison of treatment strategies for resectable locally advanced primary mucinous adenocarcinoma of the lung.可切除局部晚期原发性肺黏液性腺癌的治疗策略比较。
Cancer Med. 2023 Apr;12(8):9303-9312. doi: 10.1002/cam4.5684. Epub 2023 Feb 15.
7
Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma.肺浸润性黏液腺癌与非黏液性浸润性腺癌的术后生存比较。
BMC Pulm Med. 2023 Jan 9;23(1):9. doi: 10.1186/s12890-023-02305-x.
8
Combined Radiomic and Visual Assessment for Improved Detection of Lung Adenocarcinoma Invasiveness on Computed Tomography Scans: A Multi-Institutional Study.联合影像组学和视觉评估以提高计算机断层扫描对肺腺癌侵袭性的检测：一项多机构研究
Front Oncol. 2022 May 30;12:902056. doi: 10.3389/fonc.2022.902056. eCollection 2022.
9
Development and Validation of a Risk Stratification Model of Pulmonary Ground-Glass Nodules Based on Complementary Lung-RADS 1.1 and Deep Learning Scores.基于互补 Lung-RADS 1.1 和深度学习评分的肺磨玻璃结节风险分层模型的建立与验证。
Front Public Health. 2022 May 23;10:891306. doi: 10.3389/fpubh.2022.891306. eCollection 2022.
10
COVID-19 Pneumonia and Lung Cancer: A Challenge for the RadiologistReview of the Main Radiological Features, Differential Diagnosis and Overlapping Pathologies.新型冠状病毒肺炎与肺癌：放射科医师面临的挑战——主要影像学特征、鉴别诊断及重叠性病变综述。
Tomography. 2022 Feb 11;8(1):513-528. doi: 10.3390/tomography8010041.
本文引用的文献
1
Interobserver reproducibility study of the histological patterns of primary lung adenocarcinoma with emphasis on a more complex glandular pattern distinct from the typical acinar pattern.原发性肺腺癌组织学模式的观察者间可重复性研究，重点关注一种不同于典型腺泡模式的更复杂腺管模式。
Int J Surg Pathol. 2014 Apr;22(2):149-55. doi: 10.1177/1066896913519165. Epub 2014 Jan 29.
2
Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.肺腺癌原位、微浸润腺癌和非黏液性贴壁为主型浸润性腺癌在 I 期疾病患者中的预后意义。
Am J Surg Pathol. 2014 Apr;38(4):448-60. doi: 10.1097/PAS.0000000000000134.
3
Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma.筛状和融合腺体是高级别肺腺癌的一种模式。
Hum Pathol. 2014 Feb;45(2):213-20. doi: 10.1016/j.humpath.2013.10.011. Epub 2013 Oct 23.
4
Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease.晚期肺腺癌中新型 IASLC/ATS/ERS 分类的相关性。
Eur Respir J. 2014 May;43(5):1439-47. doi: 10.1183/09031936.00138813. Epub 2014 Jan 16.
5
Histological subtypes of solitary pulmonary nodules of adenocarcinoma and their clinical relevance.腺癌孤立性肺结节的组织学亚型及其临床相关性。
J Thorac Dis. 2013 Dec;5(6):841-6. doi: 10.3978/j.issn.2072-1439.2013.12.16.
6
Performance validation in anatomic pathology: successful integration of a new classification system into the practice setting using the updated lung non-small cell carcinoma recommendations.在解剖病理学中的性能验证：使用更新的肺非小细胞癌建议成功将新的分类系统整合到实践中。
Arch Pathol Lab Med. 2014 Jan;138(1):105-9. doi: 10.5858/arpa.2012-0750-OA.
7
Genotype-phenotype correlation in Chinese patients with pulmonary mixed type adenocarcinoma: Relationship between histologic subtypes, TITF-1/SP-A expressions and EGFR mutations.中国肺混合性腺癌患者的基因型-表型相关性：组织学亚型、TITF-1/SP-A 表达与 EGFR 突变的关系。
Pathol Res Pract. 2014 Mar;210(3):176-81. doi: 10.1016/j.prp.2013.11.013. Epub 2013 Dec 5.
8
Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.正电子发射断层扫描上的肿瘤标准化摄取值是薄层计算机断层扫描显示部分实性结节的c期IA期肺癌患者原位腺癌的一种新的预测指标。
Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):329-34. doi: 10.1093/icvts/ivt500. Epub 2013 Dec 18.
9
The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas.分子分析在非小细胞肺癌诊断和治疗中的作用。
Semin Diagn Pathol. 2013 Nov;30(4):298-312. doi: 10.1053/j.semdp.2013.11.007. Epub 2013 Nov 13.
10
Nodule characterization: subsolid nodules.结节特征：亚实性结节
Radiol Clin North Am. 2014 Jan;52(1):47-67. doi: 10.1016/j.rcl.2013.08.011. Epub 2013 Oct 6.
Zotero 插件